• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $MDAI

    Spectral AI Inc.

    Subscribe to $MDAI
    $MDAI
    Medical/Dental Instruments
    Health Care

    IPO Year: 2021

    Exchange: NASDAQ

    Recent Analyst Ratings for Spectral AI Inc.

    DatePrice TargetRatingAnalyst
    1/23/2024$4.00Buy
    BTIG Research
    See more ratings

    Spectral AI Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call

      DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential today announced that it will report financial results for the first quarter ended March 31, 2025 on Tuesday, May 13, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time to discuss the results. Investors interested in participating in the live call can dial: 833-630-1956 - U.S.412-317-1837 - International A simultaneous webcast of the call may be accessed online from the Events

      5/2/25 4:00:00 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Burn clinicians present positive findings of the DeepView® System's accuracy at the American Burn Association annual meeting

      DALLAS, April 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential today announced its successful participation at the American Burn Association annual meeting, dedicated to burn awareness and prevention. The event, held from April 7th - 11th in Phoenix, Arizona, brought together over 2,200 burn care professionals worldwide. This year's meeting showcased the latest advancements in burn care, fostered interdisciplinary collaboration, and celebrated the burn care community's dedication. Burn and Plastics Senior

      4/30/25 4:00:00 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • FDA Watch: The Quiet Gold Rush in AI-Powered Medical Devices

      Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, April 2, 2025 /PRNewswire/ -- Equity Insider News Commentary – Artificial Intelligence (AI) is quickly becoming a major force in healthcare, as use of AI applications in medical fields is growing rapidly. Researchers at Dartmouth recently conducted the first clinical trial of a therapy chatbot powered by generative AI (genAI), and found that it resulted in significant improvements in participants' symptoms. Cleveland Clinic and UAE-based G42 recently started collaborating on the advancement of even more AI in healthcare adoption, signalling an international push in this revolution. Because of this, the

      4/2/25 11:04:00 AM ET
      $AAPL
      $AMZN
      $GEHC
      $MDAI
      Computer Manufacturing
      Technology
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results

      2024 Research & Development Revenue of $30 Million Successful Results from the US Burn Validation Study On Track for Regulatory Submission in US for DeepView™ System DALLAS, March 27, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence ("AI") company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the fourth quarter ("Q4 2024") and full year ("FY 2024") ended December 31, 2024, and provided an update on its ongoing business activities. "Spectral AI achieved much in 2024. Our top-l

      3/27/25 4:55:44 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization

      DALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced the successful completion of a debt financing agreement of up to $15.0 million in funding from Avenue Venture Opportunities Fund II, L.P., a fund of Avenue Capital Group, with an initial draw down of $8.5 million. In connection with this debt financing, the Company also raised $2.7 million of equity financing from institutional as well as existing investors. With total cash on hand now of over $14 million and potential access t

      3/24/25 7:30:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Spectral IP

      DALLAS, March 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced that its wholly-owned subsidiary,  Spectral IP, Inc., has publicly filed a registration statement with the U.S. Securities and Exchange Commission ("SEC") relating to its planned spinoff through an initial public offering of its shares of common stock. Spectral IP, Inc. will be renamed SIM IP Inc. ("SIM IP") prior to the completion of this offering.

      3/20/25 4:00:00 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Announces Successful Results from its Burn Validation Study of the DeepView System

      DeepView® System outperforms burn physicians in identifying non-healing tissue Landmark Burn Validation Study, one of the largest in U.S. history, confirms DeepView's performanceSpectral AI plans FDA submission by mid-2025, targeting De Novo Clearance and rapid commercialization to transform burn care DALLAS, March 17, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, that uses multi-spectral imaging and AI algorithms to predict burn healing potential, announced the successful results of the performance of its DeepView System in connection with the completion of its Burn Validation Study. Spectral AI's DeepV

      3/17/25 7:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Completes Three Device Installations in Australia

      DALLAS, March 06, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration ("FDA") in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced the completion of the installation of three of the DeepView System devices in Australia.   The Company, in partnership with global medical device company and burn wound therapy leader PolyNovo Limited ("PolyNovo"). The Company was able to utilize the Australian Special Access Scheme (SAS) to deploy three DeepView Systems at the Concord Repat

      3/6/25 10:36:28 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call

      DALLAS, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration ("FDA") in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2024 on Wednesday, March 27, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time to discuss the results. Investors interested in participating in the live call can dial: 844-481-30

      2/28/25 8:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Strengthens Financial Position Ahead of FDA Submission

      DALLAS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration ("FDA") in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced the satisfaction of its final remaining obligations under the Company's debt facility with Yorkville Advisors. The Company retains access to additional financing of up to $17.5 million under an existing standby equity purchase agreement. "I am pleased to share this milestone as we continue advancing toward our FDA submission and work to brin

      2/18/25 7:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    Spectral AI Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cotton Richard John was granted 9,699 shares, increasing direct ownership by 17% to 66,927 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/1/25 4:00:30 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Director Mellish Martin C.B. was granted 9,699 shares, increasing direct ownership by 100% to 19,398 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      4/30/25 5:02:54 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • CFO and General Counsel Capone Vincent S. was granted 100,000 shares, increasing direct ownership by 508% to 119,700 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      4/30/25 5:02:34 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spangenberg Erich was granted 6,000 shares, increasing direct ownership by 0.96% to 628,574 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/17/24 9:15:14 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Micek Stan was granted 10,000 shares (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/14/24 11:18:11 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Dimaio John Michael bought $10,320 worth of shares (6,000 units at $1.72), increasing direct ownership by 0.40% to 2,491,908 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/14/24 11:17:43 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Capone Vincent S. was granted 10,000 shares, increasing direct ownership by 103% to 19,700 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/13/24 5:21:32 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Carlson Peter M was granted 29,411 shares (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/13/24 5:21:07 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spangenberg Erich was granted 45,000 shares, increasing direct ownership by 8% to 622,574 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/13/24 5:20:50 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Sparks Jeremiah A. was granted 6,084 shares, increasing direct ownership by 61% to 16,084 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/13/24 5:20:22 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    Spectral AI Inc. Financials

    Live finance-specific insights

    See more

    Spectral AI Inc. SEC Filings

    See more
    • Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call

      DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential today announced that it will report financial results for the first quarter ended March 31, 2025 on Tuesday, May 13, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time to discuss the results. Investors interested in participating in the live call can dial: 833-630-1956 - U.S.412-317-1837 - International A simultaneous webcast of the call may be accessed online from the Events

      5/2/25 4:00:00 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results

      2024 Research & Development Revenue of $30 Million Successful Results from the US Burn Validation Study On Track for Regulatory Submission in US for DeepView™ System DALLAS, March 27, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence ("AI") company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the fourth quarter ("Q4 2024") and full year ("FY 2024") ended December 31, 2024, and provided an update on its ongoing business activities. "Spectral AI achieved much in 2024. Our top-l

      3/27/25 4:55:44 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call

      DALLAS, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration ("FDA") in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2024 on Wednesday, March 27, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time to discuss the results. Investors interested in participating in the live call can dial: 844-481-30

      2/28/25 8:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Announces 2024 Third Quarter Financial Results

      Revenue Rose to $8.2 MillionCompany Reaffirms Timeline for Regulatory Submission to U.S. FDA Q3 2024 Overview Research & Development Revenue Rose 138% to $8.2 MillionLast Patient Out at Burn Centers for U.S. Burn Pivotal Study; Top Line Study Results Expected in Q4 2024U.S. FDA Submission on Track for Q2 2025Completed Proof-of-Concept Module for Wound Measurement Technology DALLAS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the third quarter ended S

      11/6/24 4:05:26 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call

      DALLAS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the third quarter ended September 30, 2024 on Wednesday, November 6, 2024 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discuss the results.   Investors interested in participating in the live call can dial: 833-630-1956 - U.S.412-317-1837 - International A simultaneous webcast of the call may be accessed

      10/23/24 4:50:37 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Announces 2024 Second Quarter Financial Results

      Second Quarter Revenue Totals $7.5 Million Total Enrollment Exceeds 85% for Burn Center Pivotal U.S. Clinical Trial Q2 2024 Overview Research & Development Revenue of $7.5 MillionCash Position of $6.9 MillionOn Track to Generate First Commercial Revenues in the U.K. Later this YearBurn Pivotal Study Nearing Completion Paving the Way for U.S. FDA Submission in Early 2025Announced Collaboration with PolyNovo Ltd. Providing Introduction to Australian MarketContinued Progress in Handheld Burn Wound Diagnostic TechnologyAdded to Russell Microcap® Index effective July 1, 2024 DALLAS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a

      8/12/24 4:05:09 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Schedules 2024 Second Quarter Financial Results and Conference Call

      DALLAS, July 29, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2024 on Monday, August 12, 2024 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time that day to discuss the results. Investors interested in participating in the live call can dial: 833-630-1956 - U.S.412-317-1837 - International A simultaneous webcast of the call may be accesse

      7/29/24 9:00:41 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Announces 2024 First Quarter Financial Results

      Q1 Overview Research & Development Revenue of $6.3 MillionImproved Capital Structure Reflected in Cash of $10.2 MillionDeepView AI®-Burn Devices Deployed in UK; Expect Commercial Revenue in 2H 2024 Additional Regulatory Submissions in US and UK for DeepView™ System Expected in 2024 and 2025 DALLAS, May 07, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the first quarter ended March 31, 2024 ("Q1 2024") and provided an update on its ongoing business activities. "During the

      5/7/24 4:15:00 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Schedules 2024 First Quarter Financial Results and Conference Call

      DALLAS, April 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the first quarter ended March 31, 2024 on Tuesday, May 7, 2024 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time to discuss the results. Investors interested in participating in the live call can dial: 833-630-1956 - U.S.412-317-1837 - International A simultaneous webcast of the call may be accessed online from the Event

      4/24/24 4:15:29 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary

      DALLAS, April 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Erich Spangenberg has been appointed as the Chief Executive Officer of its health care IP-focused subsidiary, Spectral IP. "Spectral AI is fortunate that our largest shareholder, Erich Spangenberg, has agreed to assume the CEO role at Spectral IP. Erich has consistently been recognized for his unrivaled track record in global IP investment, monetization, enforcement, acquisition, and licensing," said Pete Carlson, CEO of Spe

      4/24/24 9:10:36 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form EFFECT filed by Spectral AI Inc.

      EFFECT - Spectral AI, Inc. (0001833498) (Filer)

      5/8/25 12:15:21 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form S-3/A filed by Spectral AI Inc.

      S-3/A - Spectral AI, Inc. (0001833498) (Filer)

      5/2/25 4:04:29 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form S-3 filed by Spectral AI Inc.

      S-3 - Spectral AI, Inc. (0001833498) (Filer)

      4/24/25 9:00:39 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form DEFA14A filed by Spectral AI Inc.

      DEFA14A - Spectral AI, Inc. (0001833498) (Filer)

      4/17/25 4:06:02 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form DEF 14A filed by Spectral AI Inc.

      DEF 14A - Spectral AI, Inc. (0001833498) (Filer)

      4/17/25 4:04:38 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

      8-K - Spectral AI, Inc. (0001833498) (Filer)

      4/1/25 9:14:53 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form 10-K filed by Spectral AI Inc.

      10-K - Spectral AI, Inc. (0001833498) (Filer)

      3/31/25 3:19:32 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Spectral AI, Inc. (0001833498) (Filer)

      3/26/25 5:27:08 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B5 filed by Spectral AI Inc.

      424B5 - Spectral AI, Inc. (0001833498) (Filer)

      3/21/25 3:32:56 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Spectral AI, Inc. (0001833498) (Filer)

      3/17/25 4:00:22 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    Spectral AI Inc. Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Dimaio John Michael bought $10,320 worth of shares (6,000 units at $1.72), increasing direct ownership by 0.40% to 2,491,908 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/14/24 11:17:43 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    Spectral AI Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Spectral AI Inc.

      SC 13G/A - Spectral AI, Inc. (0001833498) (Subject)

      11/14/24 4:09:49 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Spectral AI Inc. (Amendment)

      SC 13G/A - Spectral AI, Inc. (0001833498) (Subject)

      4/19/24 6:49:51 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D/A filed by Spectral AI Inc. (Amendment)

      SC 13D/A - Spectral AI, Inc. (0001833498) (Subject)

      2/27/24 2:07:28 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D/A filed by Spectral AI Inc. (Amendment)

      SC 13D/A - Spectral AI, Inc. (0001833498) (Subject)

      2/26/24 4:10:49 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    Spectral AI Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BTIG Research initiated coverage on Spectral AI with a new price target

      BTIG Research initiated coverage of Spectral AI with a rating of Buy and set a new price target of $4.00

      1/23/24 7:24:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    Spectral AI Inc. Leadership Updates

    Live Leadership Updates

    See more
    • Spectral AI Set to Join Russell Microcap® Index

      DALLAS, May 29, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it is set to join the Russell Microcap® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective following the closing of US equity markets on Friday, June 28, 2024 according to a preliminary list of additions posted Friday, May 24, 2024. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as of Tuesday, April 30, 2024 ranking them by total market capitalization. Members

      5/29/24 8:31:22 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Announces Voting Results from 2024 Annual Meeting of Stockholders and the Appointment of Erich Spangenberg to the Board of Directors

      DALLAS, May 15, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced results from its 2024 Annual Meeting of Stockholders held on May 14, 2024 (the "AGM"). At the AGM, stockholders overwhelmingly approved each of the four proposals set forth by the Company. The voting results are detailed below. Six directors were elected to serve until the next Annual Meeting of Stockholders: Richard Cotton, Chairman of the Company's Board of DirectorsPeter M. Carlson, Chief Executive Officer of the

      5/15/24 6:05:21 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer

      DALLAS, April 01, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Jeremiah A. Sparks as Chief Commercialization Officer. Jeremiah has more than 20 years of medical device marketing experience, including global marketing and business strategy. Mr. Sparks will be responsible for both domestic and international product commercialization. "We are thrilled to have Jeremiah join the company as we move towards commercialization of DeepView," said Peter M. Carlson, CEO of Spectral AI.

      4/1/24 9:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Appoints Peter M. Carlson as CEO

      Appointment Paves the Way for Company's Next Chapter in Commercialization Phase of AI-Powered DeepView Device for Predictive Wound Care Carlson Brings Proven Track Record of Operating and Financial Leadership, Including with Premier Wound Care Management Companies Wensheng Fan Transitions to Chief Innovation Strategist and Senior Advisor to the CEO Company Announces Preliminary 2023 R&D Revenue; Reaffirms Full Year Revenue Guidance for 2024 and Highlights First Quarter Momentum DALLAS, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate tre

      2/29/24 5:30:52 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of Directors

      DALLAS, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in clinical wound care, today announced the appointment of Erich Spangenberg to the Board of Directors ("Board"). Mr. Spangenberg will serve as Chairman of the Company's Executive Committee as well as the Nominating and Corporate Governance Committee. "We are pleased to welcome the return of Erich to the Board of Directors, where his experience, insights and network will be an invaluable resource for our company," said Wensheng Fan, CEO of Spectral AI. "Erich's pro

      11/27/23 8:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI names Prof. Paul Chadwick, Former CEO of the Royal College of Podiatry UK, as Senior Executive for UK and EMEA

      DALLAS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Prof. Paul Chadwick as Executive Vice President of the Company's United Kingdom subsidiary. Prof. Chadwick is an experienced clinical scientist and wound care key opinion leader (KOL) with an impressive body of work including a substantial and impactful publication record, particularly in the domain of diabetic wound management. He will be responsible for the international market expansion of the Company's DeepView®

      10/24/23 8:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Adds Healthcare Services Leader and Population Health Expert Deepak Sadagopan to Board of Directors

      DALLAS, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI, MDAIW))) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Deepak Sadagopan, MHCDS, to its board of directors. A high-impact healthcare executive with more than 25 years of senior leadership experience with top Fortune-rated corporations and aggressive startup environments, he brings to the board expertise in healthcare technology and analytics along with a successful track record in product launches. Currently, Mr. Sadagopan is the Chief Operating Officer of Popula

      10/2/23 8:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care